Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.
The new findings strengthen the "RNA world" hypothesis that describes how the first life on Earth could have used RNA instead ...
Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel ...
The News-Herald on MSN
Lake County General Health District: 'Understand choices' in post-pandemic world
This is one in a series looking at what Lake County communities, agencies, and school districts experienced in 2025 and what ...
There is no age restriction in HB 917 for the purchase of ivermectin. Holcomb has also filed HB 29 , to legalize ...
The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz ...
Hosted on MSN
mRNA therapy rejuvenates immune cells in aged mice
Old mice experienced "rejuvenation" after receiving this injection. It is an injectable treatment utilizing ribonucleic acid, mRNA technology, which was used to create the COVID-19 vaccine. While ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...
An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback